E
Lixte Biotechnology Holdings, Inc. LIXT
$3.46 $0.1655.02% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -25.91% -32.25% -32.10% -30.03% -28.99%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -23.54% -29.32% -29.81% -30.04% -34.55%
Operating Income 23.54% 29.32% 29.81% 30.04% 34.55%
Income Before Tax 23.41% 29.13% 29.51% 29.65% 34.37%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 23.41% 29.13% 29.51% 29.65% 34.37%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 23.41% 29.13% 29.51% 29.65% 34.37%
EBIT 23.54% 29.32% 29.81% 30.04% 34.55%
EBITDA -- -- -- -- --
EPS Basic 29.79% 39.16% 42.49% 46.02% 50.40%
Normalized Basic EPS 29.80% 39.16% 42.49% 46.01% 50.39%
EPS Diluted 29.79% 39.16% 42.49% 46.02% 50.40%
Normalized Diluted EPS 29.80% 39.16% 42.49% 46.01% 50.39%
Average Basic Shares Outstanding 9.79% 11.84% 17.47% 27.28% 32.50%
Average Diluted Shares Outstanding 9.79% 11.84% 17.47% 27.28% 32.50%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --